Intriguingly, the potential roles of insulin in the pathogenesis and treatment of some neurological diseases, including depression, cognitive decline, and Alzheimer's disease (AD), have expanded the brain insulin signaling research field beyond the confines of diabetes. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.